Clinical trial

Efficacy of Nab-PHP Versus TCbHP in Neoadjuvant Therapy for HER2-positive Early Breast Cancer

NCT07057427

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-06-24

PhasePHASE3

Study timeline

Study start (actual)2025-06-24Date precision: day

Registry last updated2025-07-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

Nab paclitaxelDRUG

Docetaxel and CarboplatinDRUG

Trastuzumab + PertuzumabDRUG

Sponsors & collaborators

Henan Cancer Hospitallead sponsor

Mapped research locations

ZhengzhouHenan, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07057427 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.